SOPHiA Solid Tumor Solution from SOPHiA GENETICS (Lausanne, Switzerland) has a CE certification and can detect glioma molecular markers such as IDH1, IDH2, CDKN2A, BRAF, EGFR, TP53, p-TERT, and H3-3A (SOPHiA Solid Tumor Solutions, 2023). Here, BRAF is linked to central nervous system cancer.